Skip to content
Home/Companies/Healthcare/Mathieu Pharma
Mathieu Pharma

Mathieu Pharma

Healthcare·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Mathieu Pharma?

Mathieu Pharma is a French Healthcare company, currently owned by Momentum Invest since 2025.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Momentum Invest
Investor
Momentum Invest
Momentum FPCI II · 2022 · Buyout

Key facts

HQFrance
SectorHealthcare
Websitewww.pharmacieveau.fr

More from Momentum FPCI II

Other portfolio companies in the same fund.

Ma Boulangerie Café
Active
France· 2026
Mister IA
Mister IA
Active
AI/MLFrance· 2026
QYYP
Active
TMTFrance· 2025
Agriland
Agriland
Active
AgricultureFrance· 2024
Creacard
Active
FintechFrance· 2022
INFOCERT
Infocert
Active
CybersecurityFrance· 2022

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns Mathieu Pharma?

Mathieu Pharma is currently owned by Momentum Invest, through Momentum FPCI II, since 2025.

When did Momentum Invest acquire Mathieu Pharma?

Momentum Invest acquired Mathieu Pharma in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue